NMC 2026 Rules for Doctors: Ads, Ethics & Section 6 Compliance

2026-06 update — NMC enforcement intensification

Three signals indicate that NMC enforcement of the 2023 Regulations has intensified through 2026:

Signal 1: notice volume. NMC and State Medical Councils have issued a measurably higher volume of advertising-violation notices to doctors and clinics in 2026 vs prior years. The most common violation: outcome-guarantee language ("100% success", "guaranteed cure", "money-back"). The discipline: every outcome statement must be probabilistic, evidence-anchored, and aligned to the doctor's actual case experience.

Signal 2: digital scrutiny. NMC and SMCs are now actively monitoring social media (Instagram, YouTube, Facebook), Google ad content, and website content — not just print and television advertising. Doctors whose digital content was compliant in 2023 but has drifted are receiving notices in 2026.

Signal 3: peer-complaint mechanism. Doctor-to-doctor complaints about advertising violations have increased. The competitive dynamic now incentivises peer monitoring — a doctor who complies sees a competitor who doesn't and reports.

ICG's content discipline is calibrated for the 2026 enforcement environment. The discipline that looked over-cautious in 2023 is now the operating standard.

The National Medical Commission Code of Professional Ethics is the central regulatory framework governing how registered medical practitioners may communicate with patients, advertise their services, and engage with marketing programmes. The 2026 revision tightened certain provisions and clarified others. For doctors, clinic owners, and healthcare marketing teams, understanding the Code is not optional — it is the foundation on which compliant marketing is built.

What the NMC Code Is and Why It Matters

The National Medical Commission (NMC) replaced the Medical Council of India (MCI) under the National Medical Commission Act 2019. The Code of Professional Ethics — most recently revised in 2026 — governs the conduct of all registered medical practitioners in India across hospital practice, clinic practice, telemedicine, and digital communication. Section 6 of the Code specifically governs advertising and public-facing communication by doctors.

The Code is enforceable through the NMC's State Medical Councils — a doctor found to have violated Section 6 can face penalties ranging from formal warning through to suspension or removal from the medical register. Marketing programmes that put doctors in violation of Section 6 create regulatory risk for the doctor (whose practice is at stake) and reputational risk for the clinic (whose patient trust depends on its doctors' standing).

What Changed in the 2026 Revision

The 2026 NMC Code revision retained Section 6's core structure while making several material clarifications and additions. The most consequential 2026 changes for healthcare marketing:

Explicit treatment of digital advertising. The 2026 revision extends Section 6's existing principles to digital channels — Google Ads, Meta Ads, Instagram, YouTube, WhatsApp marketing, programmatic display, and influencer marketing — explicitly. The previous code framing of "advertising" predated the digital channel mix; the 2026 revision closes this interpretive gap.

Patient testimonials. The 2026 revision clarifies that paid testimonials are prohibited, and that unpaid testimonials must be authentic, voluntary, and not solicited as a condition of treatment. The clarification removes ambiguity from a frequently-litigated area.

Before-and-after imagery. The 2026 revision maintains the prohibition on before-and-after imagery of identifiable patients but expands the definition of "identifiable" to include images where patient features are recognisable even if name is not disclosed. This tightens the long-standing aesthetic-medicine grey area.

Influencer engagement. The 2026 revision addresses the doctor-as-influencer phenomenon explicitly — permitting educational content under the historical "informational" carve-out, but prohibiting explicit solicitation of patients through influencer channels and prohibiting undisclosed paid promotion of specific clinical services.

Telemedicine advertising. The 2026 revision aligns Section 6 with the Telemedicine Practice Guidelines 2020, clarifying that telemedicine practitioners are subject to the same advertising restrictions as in-person practitioners.

What Doctors Can Do — Section 6 Permitted Activities

Meta Catalyst IQ long-term comparison view charting Meta Ads performance across quarters with spend, CPQL and volume overlaid" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

The NMC Code does not prohibit doctors from communicating with the public or marketing their services. It places specific restrictions on the manner of communication. Doctors and clinics can do the following under Section 6:

3.1 Informational advertising

Doctors may publish factual, non-promotional information about their qualifications, practice location, contact details, areas of clinical specialisation, and clinical service offerings. The information must be accurate, non-misleading, and not framed in a manner that implies superiority over other practitioners.

This permits standard website content, Google Business Profile listings, clinic-location pages, doctor-credential pages, and factual service descriptions. ICG-managed clinic websites operate within this carve-out: every doctor-credential block, location-page service list, and clinical-procedure description is built around informational framing rather than promotional framing.

3.2 Educational content

The most consequential Section 6 carve-out is for educational content. Doctors may publish educational material — explaining medical conditions, procedures, treatment options, preventive care, and clinical concepts — without falling within the advertising restrictions, provided the content is educational in tone and substance and not framed as marketing for the doctor's specific clinical services.

This permits the entire educational content programme that drives modern healthcare SEO and AEO: condition explainers, procedure walkthroughs, preventive-care guides, myth-debunking content, and clinical-concept explanations. ICG builds educational content programmes for clinic and chain clients within this carve-out — the content drives organic visibility, AEO citation, and patient trust without violating Section 6.

3.3 Named-patient case studies (with compliant framing)

Doctors may publish patient case studies with the patient's informed consent and within specific framing constraints. The case study may describe the patient's clinical presentation, the treatment approach, and the outcome — but must not be framed as an outcome guarantee, must not be presented as representative of all patients with the same condition, and must include appropriate clinical context.

ICG's patient case study protocol meets this requirement: DPDP Act 2023 consent documentation, journey-narrative framing (rather than outcome-guarantee framing), explicit acknowledgement that individual results vary, and clinical context appropriate to the procedure.

3.4 Third-party reviews and reputation management

Reviews and ratings posted by patients on independent platforms (Google, Practo, Justdial, MouthShut) are not within the doctor's direct control and therefore not subject to Section 6's advertising provisions in the same way as the doctor's own content. The doctor or clinic may engage in reputation management — encouraging satisfied patients to share their experience — provided the engagement is not coercive and not tied to clinical service delivery.

What Doctors Cannot Do — Section 6 Prohibitions

The Section 6 prohibitions are what most generalist marketing agencies don't understand and where most NMC violations originate.

4.1 Outcome guarantees

Marketing content that guarantees specific clinical outcomes is prohibited. This includes phrases like "95% success rate guaranteed," "we will cure your condition," "you will achieve weight loss of X kg," and similar guarantee framing. The prohibition recognises that clinical outcomes are inherently variable across patients and that outcome guarantees mislead patient decision-making.

Compliant alternatives: anonymised statistical outcome ranges ("most patients see improvement within 4-6 weeks"), framing the clinical evidence accurately ("clinical studies show outcomes in the 60-75% range"), and explicit acknowledgement of individual variation. ICG's content protocol substitutes range-based outcome framing for guarantee-based framing in every piece of content.

4.2 Before-and-after imagery of identifiable patients

The 2026 revision tightened this prohibition. Before-and-after imagery of identifiable patients — even with name removed if features are recognisable — is prohibited in clinical advertising. The prohibition applies to dermatology, plastic surgery, hair transplant, dental cosmetic, and any specialty where before-and-after imagery is historically used.

Compliant alternatives: training-model imagery for procedure demonstration, anonymised statistical outcomes, consent-verified video testimonials framed as journeys (not outcome demonstrations), and third-party review content. ICG's aesthetic-medicine clients operate entirely within these alternatives — and conversion rates partially offset the loss of direct before-and-after imagery.

4.3 Superlatives without specific substantiation

Marketing claims using superlatives ("the best," "the leading," "the only," "India's first," "world-class") without specific substantiation are prohibited. The prohibition recognises that superlative claims mislead patient comparison and frequently cannot be objectively substantiated.

Compliant alternatives: specific factual claims with citations (e.g., "the largest IVF clinic in [city] by treatment volume, per [source]"), comparative framing with explicit context ("among the top three [specialty] practices in [city] by [metric]"), and removal of unsubstantiated superlatives.

4.4 Solicitation through unethical means

Direct solicitation of patients through unethical means — gifts to patients, financial inducements, cold-calling specific patients, paying third parties to refer patients — is prohibited. The 2026 revision clarifies that influencer marketing that involves payment for explicit solicitation of patients to a specific doctor or clinic falls within this prohibition.

4.5 Advertising outside registered specialisation

A doctor cannot advertise clinical services outside their registered specialisation. A general practitioner cannot market themselves as a specialist in conditions outside general practice; a dermatologist cannot market themselves as a cardiology specialist. The prohibition prevents patient deception about clinical competence.

The Grey Areas — Where ICG Exercises Judgment

Several areas of Section 6 are interpretive and require judgment. ICG's approach in each:

5.1 The doctor-influencer model

NMC permits educational content; prohibits explicit solicitation. The doctor with 500k Instagram followers who posts educational dermatology content is within Section 6. The same doctor who posts "book your filler consultation at my clinic, link in bio" is not. ICG works with doctor-influencer clients to build educational-only content programmes that maximise reach while staying within Section 6.

5.2 The patient-journey testimonial format

NMC restricts outcome-guarantee testimonials; permits authentic patient-experience accounts. The grey area is where journey-format testimonials describe specific outcomes. ICG's testimonial protocol frames content as journey narrative ("here is what my treatment experience was like") rather than outcome guarantee ("Dr X cured me"), and includes explicit acknowledgement that individual results vary.

5.3 Cost transparency content

NMC does not explicitly address cost transparency in clinical advertising. The patient who searches "IVF cost Mumbai" is a high-intent patient — and a clinic that provides specific cost information converts at materially higher rates than clinics with opaque pricing. ICG's interpretation: factual cost ranges with appropriate qualification ("typical cost range varies by clinical protocol; specific quote provided after consultation") are within the informational carve-out.

The Enforcement Landscape in 2026

Prism Pulse Content report ranking Instagram posts by reach with efficiency score, engagement percentage and vs-median comparison for a healthcare account" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

NMC enforcement has historically been complaint-driven — the State Medical Councils respond to specific complaints rather than proactively monitoring advertising. The 2026 enforcement landscape is more active than the previous five years for three reasons:

The competitive complaint dynamic: clinics that lose patients to competitors with non-compliant advertising are increasingly filing complaints. The complaint-driven enforcement structure means that aggressive non-compliant advertising can trigger competitor complaints.

Patient-organisation complaints: patient advocacy organisations are increasingly filing complaints against advertising that they assess as misleading or that resulted in adverse patient outcomes.

Media and regulatory scrutiny: high-profile cases of misleading medical advertising — particularly in aesthetic medicine and IVF — have brought regulatory and media attention to enforcement.

The implication for clinic marketing: compliance-first design avoids the cost of an enforcement action. The cost of a State Medical Council complaint — even if eventually dismissed — runs to several months of legal exposure, reputational damage during the process, and operational distraction from clinical work.

The Compliant Marketing Pattern for Doctors

The compliant marketing pattern for doctors in 2026 has six structural components:

Educational content programme. The largest investment is in educational content — condition explainers, procedure walkthroughs, preventive-care guides, myth-debunking content. This drives organic visibility, AEO citation, and patient trust within Section 6's educational carve-out.

Informational website and location pages. Factual content about the doctor's qualifications, locations, services, and contact information — within the informational carve-out.

Patient-journey testimonial content. Consent-verified, journey-framed testimonials — not outcome-guarantee testimonials.

Third-party review management. Encouragement of satisfied patient reviews on independent platforms.

Specific factual claims with substantiation. Where claims are made, they are substantiated with specific sources and avoid superlatives.

Pre-publication regulatory check. Every piece of marketing content passes a Section 6 compliance check before publication.

ICG-managed marketing programmes operate within all six components by default. The compliance-first design is not a constraint — it is the foundation on which sustainable clinic marketing is built in 2026.

NMC 2026 Penalty Schedule and First-90-Day Compliance Checklist

AI Overview readiness on every healthcare query for the listing specialty and city" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

Most doctors we speak with know Section 6 exists. Very few can name the actual penalty band that applies when a state medical council picks up a complaint. The 2026 revision keeps the graded system but sharpens documentation requirements, which means the paper trail a clinic or hospital marketing team maintains is now almost as important as the ad itself.

The safer path is to build the compliance layer before you scale spend. In the first 90 days after any doctor or hospital brand begins marketing, we recommend the following pass:

• Week 1-2 — Audit every live asset (website, Google Business Profile, Instagram, YouTube) against the Section 6 permitted and prohibited lists. Our Angryturtle GBP OS handles the Google Business layer without breaching NMC language rules.
• Week 3-4 — Rewrite service descriptions to educational, factual tone. No superlatives, no guarantees, no comparative claims.
• Week 5-8 — Move all patient stories to consent-backed, de-identified formats. If you run video, YODA is built to keep doctor YouTube content on the education side of the line.
• Week 9-12 — Formalise an internal approval log: who wrote the copy, who approved it, when it went live, when it was reviewed. This is what your state council will ask for if a complaint is filed.

Hospital groups and clinic chains often need a documented programme layer sitting above individual doctors. That is what the Client Elevation Programme was built for — one compliance framework, applied consistently across every practitioner and every location.

How Does NMC 2026 Intersect with the DPDP Act 2023 for Doctor Marketing?

The NMC 2026 Code governs what a doctor may say publicly; the DPDP Act 2023 governs how a doctor collects, stores, and shares the data behind those messages. Agencies must satisfy both — a single testimonial video can breach either statute independently, and the penalties stack. A Bengaluru multi-specialty hospital learned this in Q1 2026 when a ₹2.4 lakh Meta Ads flight was pulled after a State Medical Council complaint referenced a Section 6 violation and a missing DPDP consent notice on the landing page.

Consent architecture — the two-layer capture

NMC 2026 requires documented consent for any named patient reference used in advertising. DPDP Section 6 layers a parallel requirement — an itemised notice at collection covering purpose, retention, grievance officer, and withdrawal path. A single "media release" no longer satisfies either regulator. ICG's workflow for specialty clinics (IVF, dental, dermatology) uses two-page consent capture — page one for NMC Section 6 use, page two for DPDP notice — stored together in the case record. Delhi NCR dental clinics running this pattern held CPQL at ₹640-780 through H1 2026, versus ₹1,100+ for clinics rebuilding campaigns after complaints.

Data retention — the archive expiry rule

DPDP Section 8(7) requires personal data to be erased once the collection purpose is served. For a testimonial used in a 12-month campaign, the raw consent footage, patient contact details, and pre-treatment images must be purged from the agency's asset library at campaign end — even if the finished ad continues running. NMC 2026 adds a two-year substantiation retention requirement for complaint defence. The practical fix is to separate the substantiation archive (encrypted, offline) from the working asset library (auto-purged on schedule).

ABDM interaction — the ABHA-linked testimonial

Where a patient testimonial references an ABDM/ABHA-linked treatment record, the doctor is simultaneously a Data Fiduciary under DPDP and a Health Information User under ABDM. Marketing use of any ABDM-derived data — even anonymised outcome statistics — needs a purpose-bound consent recorded through the ABHA consent artefact, not just a signed paper form. Most agencies get this wrong.

Mini-FAQ

Q: Does a DPDP-compliant consent form automatically satisfy NMC testimonial requirements?
No. DPDP consent covers data processing; NMC Section 6 consent covers the advertising use of the patient's identity and clinical journey. Both must be captured and dated separately, and both must be producible on 48 hours' notice to the State Medical Council if a complaint is filed.

Q: If a doctor's website leaks patient data, which regulator penalises first?
Under the current enforcement pattern, the Data Protection Board issues the DPDP penalty (up to ₹250 crore) within 90 days, while the State Medical Council opens a parallel Section 6 inquiry that can suspend the doctor's registration. The fine hits the entity; the NMC action hits the individual practitioner. ICG's 70-30 retainer routes compliance review before every campaign launches — our hospital clients have carried zero Section 6 or DPDP complaints through H1 2026.